Cover Image

ADAM9 Promotes Glycolysis in Th17 Cells and Autoimmunity Through Activation of IGF ‐1 Signaling

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Kohei Karino, Masataka Umeda, Theodoros Vichos, Wenliang Pan, Michihito Kono, Maria G. Tsokos, George C. Tsokos
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Arthritis & Rheumatology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hypoxia Promotes the Expression of ADAM9 by Tubular Epithelial Cells, Which Enhances Transforming Growth Factor β1 Activation and Promotes Tissue Fibrosis in Patients With Lupus Nephritis
by: Masataka Umeda, et al.
Published: (2024)

Podocyte Interleukin‐23 Receptor Signaling in the Pathogenesis of Lupus Nephritis
by: Rong Fu, et al.
Published: (2025)

Aberrant Glycosylation of IgG in Children With Active Lupus Nephritis Alters Podocyte Metabolism and Causes Podocyte Injury
by: Rhea Bhargava, et al.
Published: (2025)

Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients With Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population‐Based Target Trial Emulation
by: Kevin Sheng‐Kai Ma, et al.
Published: (2024)

Precision Medicine in Pediatric Autoimmunity: Leniolisib Treatment of Childhood‐Onset Lupus Nephritis Due to Activated Phosphoinositide 3‐Kinase δ Syndrome
by: Jonathan P. Lim, et al.
Published: (2025)

Transition From Psoriasis to Psoriatic Arthritis is Characterized by Distinct Alterations in Peripheral Blood Tc17, Th17, and CD4 + Effector Memory Cells
by: Hanna Graßhoff, et al.
Published: (2025)

TWIST1 ‐Mediated Induction of AEBP1 in Fibroblast‐Like Synoviocytes Activates Transforming Growth Factor β Signaling to Drive Angiogenesis and Promote Rheumatoid Arthritis
by: Zhenyu Li, et al.
Published: (2026)

Mechanisms of B Cell Tolerance in Health and Autoimmunity
by: Sivasankaran Munusamy Ponnan, et al.
Published: (2025)

Curating Genetic Associations With Rheumatologic Autoimmune Diseases to Improve Patient Outcomes
by: S. Louis Bridges, et al.
Published: (2024)

Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune Diseases
by: Matteo Bianchi, et al.
Published: (2024)

The Inaugural NIH ‐Wide Strategic Plan for Autoimmune Disease Research (Fiscal Years 2026–2030)
by: Victoria K. Shanmugam, et al.
Published: (2025)

Systemic Autoimmune Rheumatic Disease Risk: Association With Long‐Term Exposure to Fine Particulate Matter
by: Mareva Geslin, et al.
Published: (2025)

National Mortality Databases to Assess Disease Burden in Systemic Autoimmune Diseases: A Valuable Resource But With Limitations
by: Ram Raj Singh
Published: (2026)

In Synergy With Interferon‐γ, Interleukin‐17 Activates Vascular Stromal Cells Toward a Proinflammatory Profile in Giant Cell Arteritis
by: Hélène Greigert, et al.
Published: (2026)

Environment and Systemic Autoimmune Rheumatic Diseases: What Do We Know After More Than 15 Years of Research?
by: Jaime E. Hart, et al.
Published: (2025)

Chitinase 3–Like 1 Promotes Endothelial‐to‐Mesenchymal Transition in Systemic Sclerosis via Mechanistic Target of Rapamycin Complex 1 Signaling Pathway
by: Xiuyuan Wang, et al.
Published: (2025)

2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
by: Sindhu R. Johnson, et al.
Published: (2024)

2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
by: Sindhu R. Johnson, et al.
Published: (2024)

Association of Combined Anti‐Ro52/TRIM21 and Anti‐Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation
by: Eléonore Bettacchioli, et al.
Published: (2024)

Correction to “Povetacicept, an Enhanced Dual APRIL / BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell‐Related Autoimmune Diseases”
Published: (2025)

Vitamin D and Marine n‐3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double‐Blind, Placebo‐Controlled Trial
by: Karen H. Costenbader, et al.
Published: (2024)

EAT ‐Lancet Diet Modifies the Risk of Rheumatoid Arthritis Through Metabolomic Signature
by: Jin Feng, et al.
Published: (2025)

Prothrombotic Activation of Platelet Pannexin‐1 Channels in Antiphospholipid Syndrome
by: Bruna de Moraes Mazetto Fonseca, et al.
Published: (2026)

Caffeine Inhibits Both Basal and Insulin‐Activated Urate Transport
by: Asim K. Mandal, et al.
Published: (2024)

EphB2 Receptor Promotes Dermal Fibrosis in Systemic Sclerosis
by: Erika S. A. Egal, et al.
Published: (2024)

Gut Microbiome and Osteoarthritis: Insights From the Naturally Occurring Canine Model of Osteoarthritis
by: Christina Stevens, et al.
Published: (2024)

Linezolid‐mediated Prevention of Fibroblast Activation and Tissue Fibrosis via Mitochondrial Translation Inhibition
by: Xuezhi Hong, et al.
Published: (2026)

Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib
by: Runa Kuley, et al.
Published: (2024)

Disturbed Spatial WNT Activation—A Potential Driver of the Reticularized Skin Phenotype in Systemic Sclerosis
by: Sara Chenguiti Fakhouri, et al.
Published: (2025)

Predisposal of Interferon Regulatory Factor 1 Deficiency to Accumulate DNA Damage and Promote Osteoarthritis Development in Cartilage
by: Yongsik Cho, et al.
Published: (2024)

Organizational Strategies to Promote Well‐Being and Combat Burnout in Rheumatology: Comment on the article by Calabrese et al
by: Priyanka Iyer, et al.
Published: (2024)

Clock Genes Regulate Ca 2+ Signaling and Mitochondrial Bioenergetics to Inhibit Sjögren Disease
by: Viktor R. Drel, et al.
Published: (2026)

Proteomic Profiling of the Large‐Vessel Vasculitis Spectrum Identifying Shared Signatures of Innate Immune Activation and Stromal Remodeling
by: Robert T. Maughan, et al.
Published: (2025)

Paradoxical Activation of Entheseal Myeloid Cells by JAK1 and Tyk2 Inhibitors via Interleukin‐10 Antagonism
by: Sami Giryes, et al.
Published: (2025)

A Rare RIPK3 Variant Enhances Necroptosis and Promotes Inflammation in a Still Disease–Like Autoinflammatory Syndrome
by: Longfang Chen, et al.
Published: (2026)

Drivers of subclinical vascular disease in systemic lupus erythematosus: comment on the article by Oliveira et al
by: Biao Song, et al.
Published: (2025)

Endometriosis as a comorbidity in pregnant patients with systemic lupus erythematosus: comment on the article by Nguyen et al
by: Maria I. Zervou, et al.
Published: (2026)

Long Noncoding RNA H19 Mediates STAT3 ‐Dependent Activation of Keratinocytes and Fibroblasts in Systemic Sclerosis Skin
by: Begoña Caballero‐Ruiz, et al.
Published: (2026)

Monocyte‐Derived Macrophages‐Synovial Fibroblasts Crosstalk Unravels Oncostatin Signaling Network as a Driver of Synovitis in Osteoarthritis
by: Damien Laouteouet, et al.
Published: (2025)

Endogenous Retroelement Activation is Implicated in Interferon‐α Production and Anti–Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis
by: Faye A. H. Cooles, et al.
Published: (2025)